#oncology

-Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the ...

-606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 ...

- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

- The Lien Foundation calls on governments and policy makers to hasten and improve their provision of palliative ...

- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune in ...

based companion diagnostic (CDx) in immuno-oncologyDARMSTADT, Germany & NEW YORK--(Antara/BUSINESS WIRE.

- Pathway Genomics, a global precision medical diagnostics company, announced the launch of ...

- Nine out of 10 physicians in Asia-Pacific use some form of online search to aid clinical decision-making, with ...

- Vinmec International Hospital here in Hanoi has commenced offering cancer patients advanced radiotherapy with a new ...

NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205- PEA PME eligible), a clinical-stage nanomedicine company pioneering ...

- Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of ...

- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung ...

- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its new FLOW system for use with Laboratory ...